Walleye Trading LLC Neurocrine Biosciences Inc Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $297,908 - $398,190	2,600 New	2,600 $299,000
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $834,560 - $919,936	6,400 Added 581.82%	7,500 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $116,676 - $146,036	1,100 New	1,100 $144,000
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $234,784 - $279,532	2,200 New	2,200 $262,000
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $31,860 - $42,488	400 Added 11.43%	3,900 $332,000
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $180,978 - $207,963	2,100 Added 150.0%	3,500 $336,000
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $733,326 - $838,614	-8,200 Reduced 85.42%	1,400 $136,000
Q1 2021 May 17, 2021	BUY	$87.57 - $119.4 $586,719 - $799,980	6,700 Added 231.03%	9,600 $934,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $2.31 Million - $2.88 Million	-26,600 Reduced 90.17%	2,900 $278,000
Q3 2020 Nov 16, 2020	BUY	$96.16 - $135.15 $403,872 - $567,630	4,200 Added 16.6%	29,500 $2.84 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $1.13 Million - $1.73 Million	-13,300 Reduced 34.46%	25,300 $3.09 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $353,017 - $534,672	4,700 Added 13.86%	38,600 $3.34 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $1.3 Million - $1.78 Million	15,000 Added 79.37%	33,900 $3.64 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $2.1 Million - $2.55 Million	-25,100 Reduced 57.05%	18,900 $1.7 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $1.5 Million - $1.9 Million	20,800 Added 89.66%	44,000 $3.72 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $249,516 - $329,508	-3,600 Reduced 13.43%	23,200 $2.04 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $1.19 Million - $2.16 Million	17,400 Added 185.11%	26,800 $1.91 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $405,408 - $515,985	4,100 Added 77.36%	9,400 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $399,090 - $561,747	5,300 New	5,300 $521,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account